Table 2 Description of the health antecedents of participants in the baseline
Medical antecedents | Intervention (n = 249) | Control (n = 119) | p value |
|---|---|---|---|
Family health history, n (%) | |||
Arterial hypertension | 125 (50.2) | 59 (49.6) | 0.911 |
Diabetes | 90 (36.1) | 31 (26.1) | 0.054 |
Dyslipidemia | 67 (26.9) | 27 (22.7) | 0.385 |
Arrhythmia | 20 (8.0) | 5 (4.2) | 0.172 |
Peripheral vascular disease | 42 (16.9) | 15 (12.6) | 0.290 |
Transient ischemic attack | 9 (3.6) | 5 (4.2) | 0.776 |
Cerebral vascular disease | 29 (11.7) | 9 (7.6) | 0.229 |
Myocardial infarction | 68 (27.3) | 24 (20.2) | 0.139 |
COPD | 15 (6.0) | 10 (8.4) | 0.396 |
Active cancer | 98 (39.4) | 53 (44.5) | 0.345 |
Cardiovascular risk, n (%) | |||
Current smoking | 7 (2.8) | 6 (5.0) | 0.365 |
Arterial hypertension | 93 (37.4) | 44 (37.0) | 0.945 |
Dyslipidemia | 46 (18.5) | 23 (19.3) | 0.844 |
Diabetes mellitus | 22 (8.8) | 8 (6.7) | 0.488 |
Cardiovascular disease, n (%) | |||
Arrhythmia | 13 (5.2) | 6 (5.0) | 0.942 |
Peripheral vascular disease | 29 (11.7) | 12 (10.1) | 0.656 |
Transient ischemic attack | 4 (1.6) | 4 (3.4) | 0.279 |
Cerebral vascular disease | 0 (0.0) | 1 (0.8) | 0.323 |
Myocardial infarction | 9 (3.6) | 3 (2.5) | 0.758 |
Other comorbidities, n (%) | |||
COPD | 4 (1.6) | 2 (1.7) | 1.000 |
Cancer | 53 (21.3) | 38 (31.9) | 0.027 |
Total prior surgeries | 2.0 [3.0] | 2.0 [2.0] | 0.066 |
Medications taken chronically before surgery, n (%) | |||
Antihypertensive | 93 (37.4) | 46 (38.7) | 0.809 |
Beta-blocker | 16 (6.4) | 12 (10.1) | 0.216 |
Statins | 50 (20.1) | 17 (14.3) | 0.179 |
Diuretics | 10 (4.0) | 11 (9.2) | 0.043 |
Gastric mucosal protectors | 20 (8.0) | 11 (9.2) | 0.695 |
Prophylactic antithrombotic agent | 27 (10.8) | 17 (14.3) | 0.341 |